CONNECT WITH US
HealthTech

HealthTech

Study finds some BRCA2 gene changes carry lower breast cancer risk

Medical Xpress logo

Published on

Add as a preferred source on Google
Study finds some BRCA2 gene changes carry lower breast cancer risk

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Mayo Clinic researchers, in a study published in Nature Communications, have identified a group of BRCA2 gene variants associated with a moderate risk of breast cancer, a finding that could help health care teams better assess a person's cancer risk and personalize care.

The researchers studied 70 BRCA2 gene variants that they labeled as hypomorphic variants because they only partially disrupt BRCA2 function. They examined how these variants affect the way BRCA2 works and analyzed genetic testing data from a large number of people who had undergone hereditary cancer testing.

Researchers within the study note that individuals who inherit these specific gene changes are estimated to have a 20% to 25% lifetime risk of developing breast cancer. By comparison, people with more common harmful BRCA2 variants may have a 50% to 70% lifetime risk. Because of this reduced risk, these variants are also labeled as reduced penetrance pathogenic variants.

"This shows that not all harmful BRCA2 variants carry the same level of breast cancer risk," says Fergus Couch, Ph.D., a breast cancer researcher at Mayo Clinic Comprehensive Cancer Center. "Understanding these differences could help us better match cancer prevention and screening strategies to an individual's actual risk."

The findings have potential implications for cancer screening and prevention. The researchers note that people who carry these variants may still qualify for and benefit from regular mammograms and breast MRI.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.